Condition: Migraine · Sponsor: Sichuan Purity Pharmaceutical Technology Co., Ltd.
The purpose of this study is to learn about the efficacy and safety of PRT-064040 Nasal Spray versus placebo in the acute treatment of moderate or severe migraine.
This description comes directly from the study's public registry record.
Ke Yao · 86-028-60830544 · ke.yao@btyy.com
Always discuss trial participation with your own doctor first.
| The First Medical Center of PLA General Hospital | Beijing, Beijing Municipality, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07304518